Nimer S - Search Results

1

Phase I-II study of busulfan and cyclophosphamide conditioning for transplantation in advanced multiple myeloma.

Schiller G, Nimer S, Vescio R, Lieb G, Lee M, Gajewski J, Territo M, Berenson J. Schiller G, et al. Among authors: nimer s. Bone Marrow Transplant. 1994 Jul;14(1):131-6. Bone Marrow Transplant. 1994. PMID: 7951100 Clinical Trial.

2

Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors.

Schiller G, Feig SA, Territo M, Wolin M, Lill M, Belin T, Hunt L, Nimer S, Champlin R, Gajewski J. Schiller G, et al. Among authors: nimer s. Br J Haematol. 1994 Sep;88(1):72-8. doi: 10.1111/j.1365-2141.1994.tb04979.x. Br J Haematol. 1994. PMID: 7803259

3

Comparison of twin and autologous transplants for multiple myeloma.

Bashey A, Pérez WS, Zhang MJ, Anderson KC, Ballen K, Berenson JR, To LB, Fonseca R, Freytes CO, Gale RP, Gibson J, Giralt SA, Kyle RA, Lazarus HM, Maharaj D, McCarthy PL, Milone GA, Nimer S, Pavlovsky S, Reece DE, Schiller G, Vesole DH, Hari P; Plasma Cell Disorders Working Committee. Bashey A, et al. Among authors: nimer s. Biol Blood Marrow Transplant. 2008 Oct;14(10):1118-1124. doi: 10.1016/j.bbmt.2008.07.007. Biol Blood Marrow Transplant. 2008. PMID: 18804041 Free PMC article. Clinical Trial.

4

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Among authors: nimer s. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

5

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Among authors: nimer s. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

6

Phase II study of etoposide, ifosfamide, and mitoxantrone for the treatment of resistant adult acute lymphoblastic leukemia.

Schiller G, Lee M, Territo M, Gajewski J, Nimer S. Schiller G, et al. Among authors: nimer s. Am J Hematol. 1993 Jul;43(3):195-9. doi: 10.1002/ajh.2830430307. Am J Hematol. 1993. PMID: 8352235 Clinical Trial.

7

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Schiller G, et al. Among authors: nimer s. Blood. 1992 Dec 15;80(12):2977-82. Blood. 1992. PMID: 1467513 Free article. Clinical Trial.

8

Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia.

Champlin R, Jansen J, Ho W, Gajewski J, Nimer S, Lee K, Territo M, Winston D, Tricot G, Reichert T. Champlin R, et al. Among authors: nimer s. Transplant Proc. 1991 Feb;23(1 Pt 2):1695-6. Transplant Proc. 1991. PMID: 1899162 No abstract available.

9

Long-term outcome of a phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients.

Gajewski JL, Nimer S, Saliba RM, Thomas M, Przepiorka D, Giralt S, von Besien K, Mehra R, Andersson B, Chan KW, Ippoliti C, Warkinten D, Feigs S, Territo M, Schiller G, Lebkowski J, Moseley AM, Lloyd K, von Hoeff M, Okarma T, Champlin R. Gajewski JL, et al. Among authors: nimer s. Cytotherapy. 1999;1(5):401-7. doi: 10.1080/0032472031000141284. Cytotherapy. 1999. PMID: 20426540 Clinical Trial.

10

Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.

Champlin R, Giralt S, Przepiorka D, Ho W, Lee K, Gajewski J, Nimer S, Andersson B, Wallerstein R, Ippolito C, et al. Champlin R, et al. Among authors: nimer s. Prog Clin Biol Res. 1992;377:385-94; discussion 395-8. Prog Clin Biol Res. 1992. PMID: 1438435 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page